MGFSX
Price
$10.30
Change
-$0.16 (-1.53%)
Updated
Aug 1 closing price
Net Assets
160.52M
RNPHX
Price
$68.63
Change
-$0.79 (-1.14%)
Updated
Aug 1 closing price
Net Assets
154.03B
Interact to see
Advertisement

MGFSX vs RNPHX

Header iconMGFSX vs RNPHX Comparison
Open Charts MGFSX vs RNPHXBanner chart's image
MassMutual Global R5
Price$10.30
Change-$0.16 (-1.53%)
VolumeN/A
Net Assets160.52M
American Funds New Perspective R5E
Price$68.63
Change-$0.79 (-1.14%)
VolumeN/A
Net Assets154.03B
MGFSX vs RNPHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MGFSX vs. RNPHX commentary
Aug 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGFSX is a Hold and RNPHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPHX has more cash in the bank: 154B vs. MGFSX (161M). RNPHX pays higher dividends than MGFSX: RNPHX (0.66) vs MGFSX (0.00). MGFSX was incepted earlier than RNPHX: MGFSX (21 years) vs RNPHX (10 years). MGFSX (1.03) is less costly to investors than RNPHX (0.56). RNPHX is a more actively managed with annual turnover of: 24.00 vs. MGFSX (6.00). MGFSX has a lower initial minimum investment than RNPHX: MGFSX (0) vs RNPHX (250). RNPHX annual gain was more profitable for investors over the last year : 13.01 vs. MGFSX (-4.19). RNPHX return over 5 years is better than : 38.10 vs. MGFSX (-28.52).
MGFSXRNPHXMGFSX / RNPHX
Total Expense Ratio1.030.56184%
Annual Report Gross Expense Ratio1.030.56184%
Fund Existence21 years10 years-
Gain YTD5.85811.70250%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets161M154B0%
Annual Yield % from dividends0.000.66-
Returns for 1 year-4.1913.01-32%
Returns for 3 years-20.0336.07-56%
Returns for 5 years-28.5238.10-75%
Returns for 10 years-32.39N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LGND132.721.14
+0.87%
Ligand Pharmaceuticals
ACM111.08-1.66
-1.47%
Aecom
SKYE3.41-0.16
-4.48%
Skye Bioscience
TTI3.86-0.24
-5.85%
TETRA Technologies
WINT0.60-0.07
-11.11%
Windtree Therapeutics Inc.